Articles tagged with Bacterial Proteins
Researchers at Harvard University have found that a simple circadian clock can maintain an accurate 24-hour cycle through the rhythmic addition and subtraction of phosphate groups on a single protein. This discovery builds upon previous research and has implications for understanding general feedback mechanisms in organisms.
A new study shows that spaceflight affects the genetic responses and disease-causing potential of Salmonella typhimurium, making it more infectious. The research, led by Arizona State University, reveals a key role for a master regulator called Hfq in triggering these changes.
Researchers have found that three major classes of antibiotics work by ramping up harmful free radicals in bacteria, making existing antibiotics less effective. This discovery could lead to new classes of antibiotics and improved methods for treating resistant infections.
Researchers at Boston University have found a previously unknown chain of events in bacteria that opens the door to new avenues of research. The team discovered a common process triggered by all three types of antibiotics, resulting in excessive free radical production that can be amplified or weakened to enhance lethality.
Researchers have found that the protective coat of superbug Clostridium difficile can self-assemble into regular shapes, opening up new avenues for fighting hospital superbugs and commercial applications in nanotechnology. This discovery could lead to identifying weaknesses in the coats or discovering new target molecules.
Researchers at Tufts University discovered that the CodY protein regulates the genes controlling C. difficile toxin production, which kills human intestinal cells by causing them to burst open. This understanding opens the door for developing a drug that can prevent hospital patients from falling ill.
Bacteria and nematode worms work together to kill insects using insecticidal toxins. The toxins, found in Photorhabdus luminescens, are also found in human pathogens Yersinia pestis and Yersinia pseudotuberculosis.
Researchers at Monash University uncover a molecular arms race between bacteria and the human immune system, revealing perforins as key players in defense against bacterial toxins. The discovery could lead to new ways to fight disease, including infectious diseases and transplantation rejection.
A recent study discovered that certain bacteria, including Brucella species responsible for the flu-like disorder Brucellosis, require sunlight to enhance their virulence. The researchers found that disabling the light-sensing molecule in these bacteria led to a significant drop in their ability to cause disease.
Scientists are studying Streptococcus pneumoniae bacteria grown in space to understand how it adapts and potentially poses a threat to long-duration space travelers. The bacteria were brought back from orbit frozen in 'zero-g mode' for analysis, providing valuable insights into its behavior in microgravity.
New research led by Brown University immunologist Wen-Ming Chu has uncovered a direct interaction between high-mobility group box 1 protein and toll-like receptor 9, triggering the immune response. The discovery could lead to the development of new vaccines and treatments for diseases such as cancer, asthma, and allergies.
Jan Löwe's groundbreaking research elucidated the structure and function of proteins involved in bacterial cell division, showcasing the complexity and sophistication of bacterial cells. His work highlights the importance of structural biology in understanding fundamental biological mechanisms.
Researchers describe a single bacterial protein, AvrPtoB, that can overcome plant defenses and evade immune response. The study suggests that the evolution of this protein is an example of the 'arms race' between pathogens and plants.
Researchers at Hauptman-Woodward Institute have solved the structure of a novel protein in Pseudomonas, a bacterium that causes cystic fibrosis and tuberculosis. The discovery may lead to the development of new antibiotics to prevent infection in patients with CF and TB.
Researchers at Lawrence Livermore National Laboratory discovered that certain bacteria excrete proteins that aggregate metal nanoparticles, reducing their toxicity and mobility. This phenomenon could lead to the development of protein-based methods for cleaning up polluted environments on a larger scale.
Scientists discovered bacteria in a flooded mine emit proteins that accumulate and trap metal nanoparticles, forming large aggregates that reduce mobility. This process may lead to new bioremediation strategies for toxic metals like arsenic and lead.
Researchers have discovered a way to create engineered minichromosomes in maize and attach genes to those minichromosomes. This breakthrough opens up new avenues for developing crops with multiple resistance traits, as well as producing medically useful proteins and metabolites.
The Journal of Biological Chemistry published several studies revealing new insights into cholesterol metabolism without oxygen, a compound effective against blood cancer, bacteria's quorum sensing mechanism, and HIV infection. These discoveries could lead to the development of new pharmaceuticals and treatments for related diseases.
A newly discovered bacterial enzyme may play a critical role in the pathogenesis of lung injury in cystic fibrosis patients. The study suggests that targeting this enzyme could be a viable near-term approach to improving the length and quality of life for many CF patients.
The research group has successfully isolated and characterized enterocin AS-48, a protein substance with antimicrobial activity produced by Enterococcus faecalis S-48. The findings suggest that AS-48 could have medium-term use as a food biopreservative, providing a potential innovative solution for food preservation.
Researchers at Ohio State University discovered that bacteria can turn genes on or off to control their infectiousness. The proteins NusG and RfaH play a crucial role in this process, with NusG regulating nearly all gene expression in bacteria and RfaH controlling specific sequences of the genome during transcription.
The Scripps Research Institute study provides new evidence that Nod1, a key player in the human immune system, shares similarities with plant Resistance proteins. These proteins protect plants from various pathogens, revealing a common regulatory pathway between humans and plants.
Researchers create combination proteins that trigger a stronger immune response against Lyme disease, potentially leading to more effective vaccines. The new proteins can also be used as diagnostic reagents to distinguish between disease-causing and harmless strains of bacteria.
A new diagnostic test, dubbed the 'dipstick,' can rapidly detect chemicals formed by disease-causing bacteria in food products, with a 90% accuracy rate. The test could help avoid illnesses and deaths caused by food poisoning, which affects millions annually.
Researchers at the Uniformed Services University have discovered that Deinococcus radiodurans protects itself from high doses of ionizing radiation through protein oxidation. This finding points to new avenues for radioprotection, potentially influencing cancer treatment and radioactive waste containment.
Researchers found that radiation-resistant bacteria like Deinococcus radiodurans are protected from protein damage by a chemical mechanism involving manganese ions. This new model of radiation toxicity highlights the importance of protein protection in bacterial survival, contradicting traditional views that prioritize DNA damage.
Scientists have analyzed vast amounts of marine microbial DNA, predicting over 6 million proteins and discovering hundreds of new gene families. The study provides a glimpse into the diverse world of protein families and their role in biology.
The American Chemical Society journal ACS Chemical Biology explores the latest research in cellular function from both chemical and biological perspectives. Researchers have discovered a potential new treatment for cancer by linking proteins to activate the immune system. Additionally, scientists have found that certain bacteria can in...
Researchers developed a new system to monitor disease dynamics in mice infected with meningococci, offering insights into the disease's progression and potential for improved vaccines. The study found that modified bacteria lacking certain adhesins could not attach to mucous linings, providing a clearer picture of infection processes.
A new type of protein discovered by Queen's University researchers may be useful in developing treatments for antibiotic-resistant bacteria. The protein, called YihE or RdoA, has been shown to be a potentially good target in a wide range of bacteria that cause infectious diseases.
Researchers found that proteorhodopsin helps bacteria supplement energy when respiration is impaired. When exposed to light, these bacteria can use solar power to carry out vital life processes.
Researchers found that a key protein is crucial for pneumonic plague's development. Disabling this protein slows the deadly attack, potentially giving doctors time to administer antibiotics and save patients.
Researchers discovered a new type of DNA parasite that can increase the spread of antibiotic-resistant bacteria. The 'stealth' plasmid produces a protein that helps it survive and thrive in bacteria, making it harder to eradicate with antibiotics.
Researchers at Mayo Clinic isolated nanoparticles from human kidney stones in cell cultures, identifying proteins, RNA, and DNA linked to nanoparticles. The findings suggest that nanoparticles may play a role in the development of kidney stones.
Gene-bending proteins recognize and bind tightly to bent DNA conformation, suggesting DNA plays a role in guiding correct bending protein to site on DNA. This finding challenges the conventional dogma that it is the protein that bends the DNA.
In prokaryotes, a chromosome-encoded Par protein generates a pulling force for asymmetric DNA segregation. The discovery suggests that basic eukaryotic mitosis elements evolved before multicellular organisms emerged.
Researchers have discovered a human protein that disrupts anthrax bacteria's iron scavenging system, potentially leading to new anti-anthrax drugs and diagnostic tools. The study found that siderocalin binds to bacillibactin, preventing it from capturing iron, while petrobactin is not bound by the protein.
Breakthroughs in protein interaction studies, antibiotic development, and signaling G Proteins are highlighted in ACS Chemical Biology. Researchers have also found a small molecule that controls thyroid hormone receptor activity.
Researchers at the University of Chicago have developed a vaccine that protects mice against multiple, drug-resistant strains of Staphylococcus aureus. The combined vaccine, based on four bacterial surface proteins, provided significant protection against five virulent strains and reduced bacterial load to undetectable levels.
Researchers at UGA have unraveled the complex organelle in Mycoplasma pneumoniae that enables it to move and divide. The discovery provides new insights into the mechanism of gliding motility, a crucial process for cell division, and offers potential targets for treatments.
Researchers at St. Jude Children's Research Hospital found that pieces of cell walls from Streptococcus pneumoniae bacteria hijack a protein on blood vessel lining and enter the brain and heart. Antibiotic therapy contributes to this damage by shedding more cell wall pieces.
Researchers at PNNL have successfully measured electrical charge shuttled by proteins removed from living cells, opening up possibilities for miniaturized bioreactors. The breakthrough could lead to the development of portable biofuel cells for powering small electronic devices.
A new protein, RELM-beta, has been identified as a key player in the connection between gut bacteria and inflammatory bowel disease. Research found that mice lacking this protein are protected from colitis induced by dextran sodium sulfate.
A study published in the Journal of Clinical Investigation has identified four proteins crucial for Entercoccus faecalis to form biofilms and cause endocarditis. Rats infected with E. faecalis lacking these proteins suffered less severe infections, suggesting potential new treatments.
Researchers have identified a protein, STM3117, that helps Salmonella evade immune cells, allowing the bacteria to multiply inside macrophages. The discovery presents a promising target for developing new drugs, vaccines, and rapid diagnostics to combat food poisoning caused by Salmonella.
Researchers at Rockefeller University have uncovered the mechanism by which Yersinia proteins disrupt host cell structure, killing their hosts. A mutation that impairs this process significantly reduces the bacteria's virulence, offering a potential target for new antibiotics.
In a study led by Johns Hopkins Medicine, researchers discovered that patients with chronic sinusitis who failed to respond to treatment had severely decreased immune function and lower production of key proteins. The findings suggest new treatment targets for this condition affecting an estimated 32 million Americans.
Researchers at Stanford University are advancing single-molecule microscopy, enabling real-time observation of individual molecules in living cells. This technology has the potential to reveal new processes inside living cells and provide insights into diseases such as cancer and neurological disorders.
Researchers discovered that bacteria employ a bungee-like structure called fimbriae with an adhesive protein at their tip to cling to mucous membranes. The mechanical properties of these structures allow them to grip even more tightly under force, helping bacteria persist in the human body.
A novel protein, RegIIIgamma, is produced by the intestinal lining to target and destroy bacterial invaders, offering insights into how the intestine maintains friendly relations with symbiotic microbes. The discovery may lead to new treatments for inflammatory bowel disease and improved understanding of probiotics.
Scientists at the University of York have discovered a critical element in the mode of action of DNase colicins, which kill cells by destroying their DNA. Understanding this mechanism could lead to the development of new, targeted antibiotics.
Dr. Ray Larsen is working on understanding protein communication in bacteria, particularly the outer membrane's defensive barrier. His research aims to develop drugs that can break this barrier, rendering bacteria susceptible to human defenses and certain antibiotics.
A Purdue University researcher has determined the structure of a protein that controls starvation response in E. coli, which can be targeted to combat bacterial infections. The protein is found in numerous harmful bacteria and is an excellent antibiotic target due to its high processivity.
Researchers at NIST determined the three-dimensional shape of class IV adenylyl cyclase, an enzyme found in plague bacteria Yersinia pestis. The unusual configuration may play a role in disrupting cell processes in infected hosts, highlighting the importance of molecular data for developing defenses against plague and other pathogens.
Researchers at Indiana University School of Medicine – Northwest propose that a family of proteins producing PGLYRP can be used to develop medications for HIV/AIDS patients. These proteins appear to be the front line in defending the body from infection, mounting a defense long before the body's main immune system responds.
Researchers developed a gamma-irradiated Listeria monocytogenes vaccine that elicits a strong T-cell response and protects against live challenge. The irradiated bacteria stimulate both adaptive and innate immune systems, providing a promising alternative to traditional vaccines.
Researchers have identified a possible mechanism used by an important motor protein that enables bacteria to travel through the bloodstream and infect organs such as the heart. The discovery may lead to the development of new pharmacological therapies that can target and kill bacteria, preventing or minimizing damage to the heart muscle.
Researchers have identified a common molecular machinery for initiating DNA replication in all three domains of life: Archaea, Bacteria, and Eukarya. This finding suggests that DNA replication is an ancient event that evolved millions of years ago.
Researchers from Michigan State University have uncovered a key bacterial protein that disables plant defense proteins, allowing bacteria to invade and destroy crops. This discovery has the potential to inform novel disease control strategies, particularly for human bacterial pathogens.
A heat-shock protein vaccine was found to reduce alveolar bone loss in patients with periodontal disease. The vaccine eradicated multiple pathogenic species, suggesting its potential as a treatment for periodontal disease.